Here are the 10-K annual reports from RCM Technologies Inc (RCMT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow RCMT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RCMT filings page.
RCM Technologies, Inc. filed an amended annual report to add the Part III disclosures that were originally expected to come from its 2026 proxy statement. The amendment updates information on directors, executive officers, corporate governance, executive and director compensation, security ownership, related-party oversight and auditor fees.
The filing details performance-based stock and restricted stock unit awards under the company’s equity plans, including PSUs granted to senior executives and RSUs granted to division leadership. It also outlines severance and change-in-control protections for top executives, Board committee structures, independence determinations and the company’s codes of conduct, ethics and insider trading.
RCM Technologies, Inc. files its annual report, reporting revenue of $319.4 million for the year ended January 3, 2026, up from $278.4 million a year earlier. Specialty Health Care generated 51.4% of revenue, Engineering 37.7%, and Life Sciences, Data and Solutions 10.9%.
The company highlights growing demand tied to telemedicine, behavioral health, cleaner energy infrastructure, and hybrid IT solutions. Two customers accounted for 20.8% and 13.6% of consolidated revenue, and about 9.1% of revenue came from outside the United States.
RCM remained in compliance with its revolving credit covenants, with $24.7 million borrowed and $27.1 million available, and continued a $50 million share repurchase program, buying 114,942 shares in late 2025 at an average price of $19.48.